company background image
FRE logo

Fresenius SE KGaA XTRA:FRE Voorraadrapport

Laatste prijs

€33.92

Marktkapitalisatie

€19.1b

7D

1.0%

1Y

20.8%

Bijgewerkt

06 Oct, 2024

Gegevens

Financiële gegevens bedrijf +

Fresenius SE & Co. KGaA

XTRA:FRE Voorraadrapport

Marktkapitalisatie: €19.1b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

FRE Overzicht aandelen

Fresenius SE & Co. KGaA, een bedrijf in de gezondheidszorg, levert producten en diensten voor chronisch zieke patiënten.

Over het bedrijf

Beloningen

Verhandeld tegen 61.7% onder onze schatting van de reële waarde
De winst zal naar verwachting met 23.72% per jaar groeien

Risicoanalyse

Rentebetalingen worden niet goed gedekt door de winsten

Community Narratives

Create a narrative

Narratives bring a range of perspectives from our community.

TO
Tokyo
Community Contributor

First comes the pain, then the money.

€74.00
FV
54.2% undervalued intrinsic discount
24.16%
Revenue growth p.a.
2users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
3 months ago author updated this narrative

Fresenius SE & Co. KGaA Concurrenten

Fresenius Medical Care

XTRA:FME

€11.1b

SYNLAB

HMSE:SYAB

€2.4b

Siemens Healthineers

XTRA:SHL

€57.8b

Carl Zeiss Meditec

XTRA:AFX

€6.2b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Fresenius SE KGaA
Historische aandelenkoersen
Huidige aandelenkoers€33.92
52 Week Hoogtepunt€35.03
52 Week Laag€23.93
Bèta1.07
11 maand verandering2.11%
3 maanden verandering16.76%
1 Jaar Verandering20.84%
33 jaar verandering-16.43%
5 jaar verandering-19.70%
Verandering sinds IPO2,904.45%

Recent nieuws en updates

Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Sep 18
Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Sep 03
Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

Aug 19
Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

Recent updates

Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Sep 18
Fresenius SE KGaA (ETR:FRE) Is Finding It Tricky To Allocate Its Capital

Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Sep 03
Is There Now An Opportunity In Fresenius SE & Co. KGaA (ETR:FRE)?

Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

Aug 19
Investors Still Waiting For A Pull Back In Fresenius SE & Co. KGaA (ETR:FRE)

We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Jul 15
We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

Jun 12
Fresenius SE KGaA (ETR:FRE) Has Some Difficulty Using Its Capital Effectively

At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

May 28
At €29.20, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

With Fresenius SE & Co. KGaA (ETR:FRE) It Looks Like You'll Get What You Pay For

May 02
With Fresenius SE & Co. KGaA (ETR:FRE) It Looks Like You'll Get What You Pay For

Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Mar 29
Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company

Mar 13
Fresenius SE KGaA (ETR:FRE) Could Be At Risk Of Shrinking As A Company

Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching

Feb 06
Why Fresenius SE & Co. KGaA (ETR:FRE) Could Be Worth Watching

A Look At The Fair Value Of Fresenius SE & Co. KGaA (ETR:FRE)

Jan 19
A Look At The Fair Value Of Fresenius SE & Co. KGaA (ETR:FRE)

Fresenius SE & Co. KGaA's (ETR:FRE) Shares Not Telling The Full Story

Jan 03
Fresenius SE & Co. KGaA's (ETR:FRE) Shares Not Telling The Full Story

Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Nov 28
Does Fresenius SE KGaA (ETR:FRE) Have A Healthy Balance Sheet?

Fresenius SE & Co. KGaA (ETR:FRE) Analysts Just Trimmed Their Revenue Forecasts By 34%

Nov 10
Fresenius SE & Co. KGaA (ETR:FRE) Analysts Just Trimmed Their Revenue Forecasts By 34%

Fresenius SE KGaA (ETR:FRE) Is Reinvesting At Lower Rates Of Return

Oct 27
Fresenius SE KGaA (ETR:FRE) Is Reinvesting At Lower Rates Of Return

Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Sep 03
Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Some Investors May Be Worried About Fresenius SE KGaA's (ETR:FRE) Returns On Capital

Jul 25
Some Investors May Be Worried About Fresenius SE KGaA's (ETR:FRE) Returns On Capital

We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

Jun 19
We Think Fresenius SE KGaA (ETR:FRE) Is Taking Some Risk With Its Debt

At €25.59, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

Jun 01
At €25.59, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

Capital Allocation Trends At Fresenius SE KGaA (ETR:FRE) Aren't Ideal

Apr 18
Capital Allocation Trends At Fresenius SE KGaA (ETR:FRE) Aren't Ideal

Fresenius SE KGaA's (ETR:FRE) Soft Earnings Are Actually Better Than They Appear

Mar 13
Fresenius SE KGaA's (ETR:FRE) Soft Earnings Are Actually Better Than They Appear

These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively

Mar 10
These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively

Are Investors Undervaluing Fresenius SE & Co. KGaA (ETR:FRE) By 38%?

Feb 23
Are Investors Undervaluing Fresenius SE & Co. KGaA (ETR:FRE) By 38%?

Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Feb 08
Is It Too Late To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence

Jan 03
The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence

These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively

Nov 28
These 4 Measures Indicate That Fresenius SE KGaA (ETR:FRE) Is Using Debt Extensively

Should You Investigate Fresenius SE & Co. KGaA (ETR:FRE) At €21.71?

Oct 23
Should You Investigate Fresenius SE & Co. KGaA (ETR:FRE) At €21.71?

The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence

Oct 01
The Returns On Capital At Fresenius SE KGaA (ETR:FRE) Don't Inspire Confidence

Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Aug 07
Is Fresenius SE KGaA (ETR:FRE) Using Too Much Debt?

Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Jul 20
Is It Time To Consider Buying Fresenius SE & Co. KGaA (ETR:FRE)?

Fresenius SE KGaA (ETR:FRE) May Have Issues Allocating Its Capital

Jul 02
Fresenius SE KGaA (ETR:FRE) May Have Issues Allocating Its Capital

Fresenius SE KGaA (ETR:FRE) Is Increasing Its Dividend To €0.92

Apr 28
Fresenius SE KGaA (ETR:FRE) Is Increasing Its Dividend To €0.92

At €34.09, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

Apr 17
At €34.09, Is Fresenius SE & Co. KGaA (ETR:FRE) Worth Looking At Closely?

Fresenius SE KGaA (ETR:FRE) Is Paying Out A Larger Dividend Than Last Year

Apr 02
Fresenius SE KGaA (ETR:FRE) Is Paying Out A Larger Dividend Than Last Year

Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital

Mar 27
Fresenius SE KGaA (ETR:FRE) Could Be Struggling To Allocate Capital

Fresenius SE KGaA's (ETR:FRE) Upcoming Dividend Will Be Larger Than Last Year's

Feb 24
Fresenius SE KGaA's (ETR:FRE) Upcoming Dividend Will Be Larger Than Last Year's

Is Now An Opportune Moment To Examine Fresenius SE & Co. KGaA (ETR:FRE)?

Jan 13
Is Now An Opportune Moment To Examine Fresenius SE & Co. KGaA (ETR:FRE)?

Here's Why Fresenius SE KGaA (ETR:FRE) Has A Meaningful Debt Burden

Dec 29
Here's Why Fresenius SE KGaA (ETR:FRE) Has A Meaningful Debt Burden

Rendement voor aandeelhouders

FREDE HealthcareDE Markt
7D1.0%-0.03%-1.9%
1Y20.8%11.3%12.3%

Rendement versus industrie: FRE overtrof de German Healthcare industrie, die het afgelopen jaar een rendement 10 % opleverde.

Rendement versus markt: FRE overtrof de German markt, die het afgelopen jaar een rendement opleverde van 13.8 %.

Prijsvolatiliteit

Is FRE's price volatile compared to industry and market?
FRE volatility
FRE Average Weekly Movement2.9%
Healthcare Industry Average Movement3.5%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.8%
10% least volatile stocks in DE Market2.4%

Stabiele aandelenkoers: FRE heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van FRE is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
1912175,771Michael Senwww.fresenius.com

Fresenius SE & Co. KGaA, een bedrijf in de gezondheidszorg, levert producten en diensten voor chronisch zieke patiënten. Het bedrijf is actief via vier segmenten: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios en Fresenius Vamed. Het segment Fresenius Medical Care biedt producten en diensten voor patiënten met chronisch nierfalen.

Fresenius SE & Co. KGaA Samenvatting

Hoe verhouden de winst en inkomsten van Fresenius SE KGaA zich tot de beurswaarde?
FRE fundamentele statistieken
Marktkapitalisatie€19.11b
Inkomsten(TTM)€721.00m
Inkomsten(TTM)€22.63b

26.5x

Koers/Winstverhouding

0.8x

P/S-verhouding

Is FRE overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
FRE resultatenrekening (TTM)
Inkomsten€22.63b
Kosten van inkomsten€17.41b
Brutowinst€5.23b
Overige uitgaven€4.51b
Inkomsten€721.00m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 06, 2024

Winst per aandeel (EPS)1.28
Brutomarge23.09%
Nettowinstmarge3.19%
Schuld/Eigen Vermogen Verhouding61.2%

Hoe presteerde FRE op de lange termijn?

Bekijk historische prestaties en vergelijking